daunorubicin has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 112 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 51 (45.54) | 18.7374 |
1990's | 32 (28.57) | 18.2507 |
2000's | 23 (20.54) | 29.6817 |
2010's | 6 (5.36) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chao, T; Huang, L; Jiang, Y; Peng, H; Shen, Q; Thapa, S; Yang, K; Yu, S; Zhang, L; Zhou, T | 1 |
Chinceşan, MI; Gozar, H; Horvath, E; Mărginean, CO; Meliţ, LE | 1 |
Bruckner, T; Hensel, M; Ho, AD; Kriegsmann, K; Kriegsmann, M; Rieger, M; Schwarzbich, MA; Sitter, S; Witzens-Harig, M; Wuchter, P | 1 |
Amoêdo, ND; Apa, AG; Bacchi, CE; Da Silva Robaina, MC; Klumb, CE; Machado, AS; Magalhães De Rezende, LM | 1 |
Gandhi, MK; Jones, K | 1 |
Alfonso, R; Miralles, J; Moragón, M; Onrubia, J; Pérez-Crespo, M; Requena, L; Sevila, A | 1 |
Handa, H; Isozumi, K; Komatsumoto, S; Motohashi, S; Nara, M | 1 |
Al Awadi, S; Al Shemmari, S; Bajciova, V; Mottl, H; Nemec, J | 1 |
Azzarà, A; Caracciolo, F; Cecconi, N; Cervetti, G; Petrini, M | 1 |
Filippa, DA; Mora, J; Qin, J; Wollner, N | 1 |
DUBOST, M; GANTER, P; MARAL, R; NINET, L; PINNERT, S; PREUDHOMME, J; WERNER, GH | 2 |
Ogawa, M | 1 |
Boronovskaia, LE; Korman, DB; Maslova, IA; Mikaélian, SG | 1 |
Aita, P; Basso, B; Boiocchi, M; Corona, G; Ruolo, G; Rupolo, M; Sorio, R; Toffoli, G | 1 |
Al-Izzi, M; Constantinou, J; McNicholas, TA; Nitkunan, T | 1 |
Sun, XF; Wang, ZH; Wang, ZQ; Xia, Y; Zhang, CQ; Zhen, ZJ | 1 |
Kajdas, L; Krawczuk-Rybak, M; Muszynska-Roslan, K; Sawicka-Zukowska, M; Sonta-Jakimczyk, D; Szczepanski, T | 1 |
Arlotta, A; Larocca, LM; Maurizi, P; Riccardi, R; Ruggiero, A | 1 |
Bárdi, E; Bobok, I; Kappelmayer, J; Kiss, C; V Oláh, A | 1 |
Arthur, C; Bond, R; Enno, A; Grigg, A; Herrmann, R; Hertzberg, M; Marlton, P; Mitchell, PL; Seymour, JF | 1 |
Anderson, JR; Chilcote, RR; Coccia, P; Exelby, P; Hammond, D; Jenkin, DT; Kersey, J; Kushner, J; Meadows, AT; Siegel, S; Wilson, JF | 1 |
Averbukh, LA; Bazhanov, VS; Gol'dberg, LE; Povarov, LS; Tarasova, VE | 1 |
Aleksander, SK; Iakushkina, IV; Liashenko, VA | 1 |
Kabiev, OK; Rakhimov, KD; Vermenichev, SM | 1 |
Bazhanov, VS; Gol'dberg, LE; Povarov, LS; Shepelevtseva, NG; Vertogradova, TP | 1 |
Averbukh, LA; Bazhanov, VS; Gol'dberg, LE; Olsuf'eva, EN; Povarov, LS | 1 |
Bazhanov, VS; Filippos'iants, ST; Olsuf'eva, EN; Povarov, LS; Shepelevtseva, NG | 1 |
Filatov, PP; Vatin, AE | 1 |
Tisman, G; Wu, SJ | 1 |
Efferth, T; Fabry, U; Glatte, P; Osieka, R | 1 |
Lizard, G; Lizard-Nacol, S; Maynadié, M; Poupon, MF; Roignot, P | 1 |
Abe, T; Hirao, A; Kawano, Y; Okamoto, Y; Saito, S; Sato, J; Shimizu, T; Suzue, T; Takaue, Y; Watanabe, T | 1 |
Agretto, A; Auricchio, U; Casale, F; Giuliano, M; Iacono, A; Iarussi, D; Indolfi, P; Murano, A | 1 |
Almeida, MT; Britto, JL; Cristofani, LM; Maksoud, JG; Maluf, PT; Manissadjian, A; Odone Filho, V; Pontes, E | 1 |
Anderson, JR; Chilcote, RR; Coccia, PF; Exelby, PR; Jenkin, RD; Kjeldsberg, CR; Meadows, AT; Siegel, S; Sposto, R; Wilson, JF | 1 |
Adler-Moore, JP; Forssen, EA; Krasieva, TB; Lee, MJ; Malé-Brune, R; Schmidt, PG; Shimizu, S; Tromberg, BJ | 1 |
Braess, J; Hiddemann, W; Kaufmann, CC; Kern, W; Kühn, S; Rührs, H; Schleyer, E; Sträubel, G; Unterhalt, M | 2 |
Dyson, PG; Juttner, CA; Roberts, MM; To, LB; Willson, K | 1 |
Chong, R; Goh, YT; Lee, LH; Ng, HS; Tan, P; Wong, GC | 1 |
Baltes-Engler, S; Dederichs, B; Diehl, V; Engelhard, M; Engert, A; Küpper, F; Lathan, B; Reiser, M; Scheulen, ME; Schnell, R; Tesch, H; Wilhelm, M; Winterhalter, B; Wörmann, B | 1 |
Bradley, SJ; Gosriwitana, I; Hider, RC; Porter, JB; Srichairatanakool, S | 1 |
Cavenagh, JD; Johnson, SA; Kelsey, SM; Newland, AC; Richardson, DS; Tighe, M | 1 |
Anami, K; Asami, K; Chin, M; Fujimoto, T; Hatae, Y; Hirota, T; Horikoshi, Y; Ito, M; Iwai, A; Kaneko, Y; Katano, N; Kataoka, S; Kikuchi, M; Koizumi, S; Miyawaki, T; Mugisima, H; Nakayama, M; Nishikawa, K; Osima, K; Suzumiya, J; Taga, T; Tanaka, A; Tsurusawa, M; Watanabe, A; Yanase, T | 1 |
Mora, J; Wollner, N | 1 |
Bernacer Borja, M; Contra Gómez, T; Gil López, C; López Pérez, J; Martín Ramos, N; Melero Moreno, C; Palacios López, ME; Torres Valdivieso, MJ; Valverde Moreno, F; Vivanco Martínez, JL | 1 |
Cocorocchio, E; Corsini, C; D'Incalci, M; Ferrucci, PF; Ghielmini, M; Mancuso, P; Martinelli, G; Mezzetti, M; Mori, A; Paolucci, M; Riggi, M; Tealdo, F; Zucchetti, M | 1 |
Armata, J; Bogusławska-Jaworska, J; Bubała, H; Dłuzniewska, A; Kazanowska, B; Kowalczyk, J; Kołecki, P; Matysiak, M; Rokicka-Milewska, R; Sońta-Jakimczyk, D; Sopyło, B; Stańczak, E; Stefaniak, MJ; Stefańska, K; Wróbel, G | 1 |
Bamborschke, S; Diehl, V; Hegener, P; Re, D; Schwenk, A; Tesch, H | 1 |
Ambinder, RF; Byr, JC; Diehl, L; Flinn, IW; Goodman, SN; Gore, S; Jamison, J; Miller, CB; Post, L; Willis, C | 1 |
Medvedev, PV; Nikitin, EA; Pivnik, AV | 1 |
Dumontet, C | 1 |
Bernstein, J; Boswell, W; Buchanan, LA; Espina, BM; Justice, GR; Kolitz, J; Letzer, J; Levine, AM; McDonald, D; Myers, A; Nathwani, B; Rarick, MU; Roberts, L; Traynor, A; Tulpule, A | 1 |
Fletcher, BD; Harrison, PL; Kaste, SC; Kennedy, W; Neel, MD; Pui, CH; Razzouk, BI; Relling, MV; Ribeiro, RC; Rubnitz, JE; Sandlund, JT | 1 |
Cavenagh, JD; Cervi, P; Grant, I; Gray, A; Hughes, A; Kelsey, SM; McBride, NC; Mills, MJ; Newland, AC; Schey, S; Ward, MC | 1 |
Chilcote, RR; Kadin, ME; Kjeldsberg, C; Krailo, MD; Meadows, AT; Morse, M; Siegel, SE; Sposto, R; Steinherz, PG; Termuhlen, AM | 1 |
Ericsson, SM; Glimelius, BL; Larsson, RL; Nygren, HP; Sundström, C | 1 |
Amiel, JL; Hayat, M; Mathé, G; Pouillart, P; Schwarzenberg, L; Tubiana, M | 1 |
Hirano, S; Hori, S; Inui, T; Ishizuka, M; Oki, T; Shirai, M; Takeuchi, T; Tsukagoshi, S; Umezawa, H | 1 |
Muto, K; Nishimura, T; Suzuki, H; Tanaka, N | 1 |
Stepanova, ES | 1 |
Gálfi, I; Koós, R; Révész, T; Schuler, D; Virág, I | 1 |
Blair, DG | 1 |
Gordina, GA; Gubin, AN; Kiselev, AV; Kosechkina, NA; Morozova, OV | 1 |
Armata, J; Balwierz, W; Skoczeń, S; Tacik, J | 1 |
Quah, TC; Siegel, SE; White, L | 1 |
Büchner, T; Hiddemann, W; Kewer, U; Reuter, C; Rolf, C; Schleyer, E; Uhrmeister, C; Unterhalt, M; Wörmann, B; Zühlsdorf, M | 1 |
Frisch, H; Schuster, E; Thun-Hohenstein, L | 1 |
Endo, N; Imai, S; Shimamoto, Y | 1 |
Coulter, DM; Forssen, EA; Proffitt, RT | 1 |
Kosaka, M; Miyamoto, Y; Mizuguchi, T; Tamura, K | 1 |
Gol'dberg, LE; Iudina, OI; Olsuf'eva, EN; Povarov, LS; Shepelevtseva, NG; Tarasova, VE; Ul'ianova, LA | 1 |
de Andrea, ML; de Camargo, B; Melaragno, R | 1 |
Nachman, J | 1 |
Bladé, J; Carreras, E; Cervantes, F; Grañena, A; Marín, P; Nomdedeu, B; Ribera, JM; Rozman, C; Sierra, J; Urbano-Ispizua, A | 1 |
Chessells, JM; Wheeler, K | 1 |
Bychkova, EN; Gol'dberg, LE; Iudina, OI; Olsuf'eva, EN; Povarov, LS; Shepelevtseva, NG; Tarasova, VE; Ul'ianova, LA | 1 |
Petriev, VM; Prusova, RM; Vatin, OE | 1 |
Burnelli, R; Mancini, AF; Paolucci, G; Paolucci, P; Pession, A; Rosito, P; Serra, L; Vecchi, V; Vivarelli, F | 1 |
Badía Torroella, RM; Cubells Riero, J; González Rivero, MA; Illa Sala, J; Melo Valls, M; Pardo García, N; Turmo Martí, J; Vela Ferrer, E | 1 |
Wollner, N | 1 |
Castel, V; Ferris, J; Mínguez, JR; Verdeguer, A | 1 |
Bezanilla Regato, JL; Burgos, J; Moya Calderón, E; Navajas Gutiérrez, A; Zubeldia Sánchez, J | 1 |
Armata, J; Dłuzewska, A | 1 |
Berard, C; Callihan, T; Falletta, J; Hvizdala, EV; Sabio, H; Shuster, JJ; Sullivan, M; Wharam, MD | 1 |
Correa Alves, A; de Andrea, ML; de Camargo, B; Franco, EL; Machado, JC | 1 |
Ikeda, N; Ikuno, Y; Kikuchi, M; Nibu, K; Okamura, J; Tasaka, H; Yamada, S | 1 |
Di Lauro, L; Lopez, M; Papaldo, P | 1 |
Colly, LP; Peters, WG; Willemze, R | 1 |
Chang, TT; Chen, TS; Chiou, SS; Perng, JJ | 1 |
Arlin, Z; Gee, T; Higgins, C; Kempin, S; Koziner, B; McKenzie, S; Mertelsmann, R; Schauer, P; Slater, DE; Straus, D | 1 |
Makukho, LV; Olsuf'eva, EN; Povarov, LS; Salimova, EI; Volkolupova, OP | 1 |
Setdikov, RA | 1 |
Gallego Melcón, S; Macía Martí, J; Pérez Payarols, J; Prats Viñas, J; Sánchez de Toledo, J | 1 |
Fibbe, WE; Kootte, AM; Lie, R; Peters, WG; Rodenburg, CJ; van Berkel, M; van Hennik, MB; Veltkamp, JJ; Willemze, R | 1 |
Boyett, J; Crist, W; Doering, EJ; Hvizdala, E; Pullen, J; Ruymann, F; Steuber, CP; Sullivan, MP; Trueworthy, R | 1 |
Fortuna, E; Fossati-Guglielmoni, A; Massimo, L | 1 |
Baledent, M; Bens, JL; Faille, N; Messerschmitt, J; Quiret, JC | 1 |
Gutjahr, P | 1 |
Bateman, CJ; Beard, ME; Crowther, D; Malpas, JS; Whitehouse, JM | 1 |
Brunning, RD; Kennedy, BJ; Weiss, RB | 1 |
Dienstl, F; Gmeiner, R; Knapp, E; Schwingshackl, A; Schwingshackl, H | 1 |
Cohen, M; Edwards, JA; Freeman, AI; Sinks, LF | 1 |
Gerhartz, H; Staeuber, PG | 1 |
Bevilacqua, L; Bonomini, B; Conte, G; Fiorentino, M; Grigoletto, E; Patrese, P; Schiatti, F; Vangelista, R | 1 |
Hawk, IA; Levy, CC; Russell, DH; Schimpff, SC | 1 |
Bile, G; De Biasi, R | 1 |
Mashburn, LT | 1 |
Esposito, S; Taylor, LA | 1 |
Bloomfield, CD; Brunning, RD; Kennedy, BJ | 1 |
Kennedy, BJ; Theologides, A; Yarbro, JW | 1 |
7 review(s) available for daunorubicin and Diffuse Mixed Small and Large Cell Lymphoma
Article | Year |
---|---|
Non-Hodgkin lymphoma, diagnostic, and prognostic particularities in children - a series of case reports and a review of the literature (CARE compliant).
Topics: Abdominal Pain; Anemia, Iron-Deficiency; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Diarrhea; Fatal Outcome; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Prognosis; Treatment Outcome; Vincristine; Vomiting; Weight Loss | 2018 |
[Plasmacytoid dendritic cell tumor].
Topics: Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dendritic Cells; Disease Progression; Doxorubicin; Humans; Immunophenotyping; Leukemia, Myelomonocytic, Acute; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Middle Aged; Prednisone; Prognosis; Remission Induction; Skin Neoplasms; Transplantation, Homologous; Vincristine | 2011 |
[Hematologic tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Doxorubicin; Hematologic Neoplasms; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 2003 |
Testicular granulocytic sarcoma, a source of diagnostic confusion.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Nucleus; Cyclophosphamide; Cytarabine; Cytoplasmic Granules; Daunorubicin; Diagnosis, Differential; Diagnostic Errors; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Sarcoma, Myeloid; Testicular Neoplasms; Vincristine | 2004 |
Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; CD4 Antigens; CD56 Antigen; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Dendritic Cells; Dexamethasone; Humans; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Remission Induction; Skin Neoplasms; Vincristine | 2006 |
Non-Hodgkin's lymphomas in children. II. Treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Doxorubicin; Humans; Immunologic Factors; Lymphoma, Non-Hodgkin; Meningeal Neoplasms; Methotrexate; Prednisolone; Prednisone; Prognosis; Remission Induction; Survival Rate; Vincristine | 1992 |
Therapy for childhood non-Hodgkin's lymphomas, nonlymphoblastic type. Review of recent studies and current recommendations.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Brain Neoplasms; Cell Differentiation; Child; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Daunorubicin; Doxorubicin; France; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Multicenter Studies as Topic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Rate; United States; Vincristine | 1990 |
23 trial(s) available for daunorubicin and Diffuse Mixed Small and Large Cell Lymphoma
Article | Year |
---|---|
Efficacy and toxicity of liposomal daunorubicin included in PVABEC regimen for aggressive NHL of the elderly.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Disease Progression; Disease-Free Survival; Drug Carriers; Female; Follow-Up Studies; Humans; Liposomes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Pain; Remission Induction; Survival Analysis; Survival Rate; Thrombocytopenia; Treatment Outcome | 2003 |
[Results of a phase I-II clinical trial of Emoxyl, a novel antineoplastic anthracycline].
Topics: Aged; Anthracyclines; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Small Cell; Daunorubicin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Sarcoma, Kaposi; Treatment Outcome | 2004 |
A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Humans; Infections; Liposomes; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Prednisolone; Prognosis; Survival Analysis; Vincristine | 2008 |
Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2).
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Clinical Trials as Topic; Cyclophosphamide; Daunorubicin; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Random Allocation; Vincristine | 1983 |
Protective effect of coenzyme Q10 on anthracyclines cardiotoxicity: control study in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Child; Coenzymes; Daunorubicin; Echocardiography; Humans; Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; Treatment Outcome; Ubiquinone; Ventricular Function, Left | 1994 |
Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Survival Rate; Vincristine | 1993 |
Oral idarubicin pharmacokinetics--correlation of trough level with idarubicin area under curve.
Topics: Acute Disease; Administration, Oral; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Cytarabine; Daunorubicin; Drug Administration Schedule; Humans; Idarubicin; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Metabolic Clearance Rate; Middle Aged | 1996 |
Peripheral blood stem cells mobilized from patients with acute myeloid leukaemia have different platelet repopulating abilities compared with those mobilized from patients with other diseases.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Bone Marrow; Cell Differentiation; Cell Lineage; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Megakaryocytes; Multiple Myeloma; Ovarian Neoplasms; Platelet Count; Thioguanine; Time Factors | 1996 |
A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Individuality; Lymphoma, Non-Hodgkin; Male; Middle Aged | 1997 |
Early evaluation of liposomal daunorubicin (DaunoXome, Nexstar) in the treatment of relapsed and refractory lymphoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Liposomes; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia | 1997 |
[Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
Topics: Adolescent; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine | 1998 |
[The treatment results in children diagnosed with non-Hodgkin's lymphomas and acute B-cell lymphoblastic leukemias treated by the BFM protocols. The report of the POGM (Pediatric Oncology Group of Madrid)].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Time Factors; Vincristine | 1998 |
A dose-finding study of liposomal daunorubicin with CVP (COP-X) in advanced NHL.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Dose-Response Relationship, Drug; Female; Humans; Liposomes; Liver; Lymphoma, Non-Hodgkin; Male; Maximum Tolerated Dose; Middle Aged; Prednisone; Remission Induction; Vincristine | 2000 |
[The therapeutic efficacy and toxicity of the liposomal form of daunorubicin (Daunoxome) in lymphosarcoma patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Heart; Humans; Liposomes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Time Factors; Vincristine | 2000 |
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Daunorubicin; Drug Delivery Systems; Female; Humans; Infusions, Intravenous; Liposomes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neutropenia | 2001 |
Liposomal daunorubicin (DaunoXome) in combination with cyclophosphamide, vincristine and prednisolone (COP-X) as salvage therapy in poor-prognosis non-Hodgkins lymphoma.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Liposomes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prognosis; Remission Induction; Salvage Therapy; Survival Analysis; Therapeutic Equivalency; Treatment Outcome; Vincristine | 2001 |
Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Follow-Up Studies; Heart Diseases; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Prednisone; Recurrence; Stomatitis; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine | 2001 |
Non-Hodgkin's lymphomas in children. II. Treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Doxorubicin; Humans; Immunologic Factors; Lymphoma, Non-Hodgkin; Meningeal Neoplasms; Methotrexate; Prednisolone; Prednisone; Prognosis; Remission Induction; Survival Rate; Vincristine | 1992 |
A new treatment protocol for childhood non-Hodgkin's lymphoma: preliminary evaluation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Premedication; Randomized Controlled Trials as Topic; Recurrence; Survival Rate; Vincristine | 1990 |
[Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spain; Survival Rate; Teniposide; Thioguanine; Vincristine | 1990 |
Lymphoblastic lymphoma in children--a randomized trial comparing LSA2-L2 with the A-COP+ therapeutic regimen: a Pediatric Oncology Group Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Doxorubicin; Female; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Prednisone; Random Allocation; Vincristine | 1988 |
Lymphoblastic lymphoma in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Thioguanine; Vincristine | 1986 |
Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Marrow; Carmustine; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Meningeal Neoplasms; Methotrexate; Neoplasm Staging; Prednisone; Prognosis; Radiotherapy Dosage; Thioguanine; Vincristine | 1985 |
83 other study(ies) available for daunorubicin and Diffuse Mixed Small and Large Cell Lymphoma
Article | Year |
---|---|
Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab.
Topics: Adult; Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Doxorubicin; Female; Humans; Immunotherapy; Incidence; Lung Diseases, Interstitial; Lymphoma, Non-Hodgkin; Male; Middle Aged; Polyethylene Glycols; Prednisone; Retrospective Studies; Rituximab; Vincristine | 2018 |
Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Recurrence; Remission Induction; Retrospective Studies; Survival Analysis; Time Factors; Transplantation, Autologous; Treatment Outcome; Vincristine | 2018 |
Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; DNA, Viral; Epstein-Barr Virus Infections; Epstein-Barr Virus Nuclear Antigens; Female; Herpesvirus 4, Human; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Monitoring, Physiologic; Outcome Assessment, Health Care; Polymerase Chain Reaction; Prednisone; Prognosis; Vincristine | 2010 |
Can a blood test monitor lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; DNA, Viral; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Monitoring, Physiologic; Outcome Assessment, Health Care; Polymerase Chain Reaction; Prednisone; Prognosis; Vincristine | 2010 |
CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
Topics: Acute Disease; Aged; Antigens, CD; Antigens, CD7; Antigens, Differentiation, Myelomonocytic; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; CD56 Antigen; Cytarabine; Daunorubicin; Diagnosis, Differential; Etoposide; Fatal Outcome; Humans; Idarubicin; Killer Cells, Natural; Leukemia, Myeloid; Leukemic Infiltration; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Mitoxantrone; Myeloid Cells; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma, Myeloid; Sialic Acid Binding Ig-like Lectin 3 | 2002 |
High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kuwait; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Mercaptopurine; Mesna; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Survival Rate; Thioguanine; Treatment Outcome; Vincristine | 2003 |
Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Radiotherapy Dosage; Survival Rate; Treatment Outcome; Vincristine | 2003 |
[A NEW ANTIBIOTIC WITH CYTOSTATIC PROPERTIES: RUBIDOMYCIN].
Topics: Adenocarcinoma; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Benzopyrenes; Carcinoma, Ehrlich Tumor; Daunorubicin; Leukemia; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mice; Neoplasms; Research; Sarcoma 180; Sarcoma, Experimental; Streptomyces; Toxicology | 1963 |
RUBIDOMYCIN: A NEW ANTIBIOTIC WITH CYTOSTATIC PROPERTIES.
Topics: Animals; Anti-Bacterial Agents; Carcinoma, Ehrlich Tumor; Daunorubicin; Leukemia; Leukemia, Experimental; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mice; Neoplasms; Neoplasms, Experimental; Pathology; Research; Sarcoma 180; Sarcoma, Experimental; Toxicology | 1964 |
Pharmacokinetic comparison of 120-hour infusion versus hyperfractionated oral administration of idarubicin.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Area Under Curve; Daunorubicin; Female; Humans; Idarubicin; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged | 2004 |
[Primary study of relationship between serum level of VEGF and non-Hodgkin's lymphoma in children and adolescent patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Vascular Endothelial Growth Factor A; Vincristine | 2004 |
Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Female; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Osteonecrosis; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Retrospective Studies; Vincristine | 2006 |
Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer.
Topics: Acetylglucosaminidase; Adolescent; Adult; Albuminuria; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Child; Child, Preschool; Creatinine; Daunorubicin; Doxorubicin; Epirubicin; Female; Humans; Idarubicin; Infant; Kidney Diseases; Kidney Tubules, Proximal; Lymphoma, Non-Hodgkin; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Retrospective Studies | 2007 |
[Synthesis and antitumor properties of carminomycin 13-cyclohexylidenhydrazone].
Topics: Administration, Oral; Animals; Carubicin; Chemical Phenomena; Chemistry; Cyclohexanones; Daunorubicin; Injections, Intravenous; Lymphoma, Non-Hodgkin; Mice; Neoplasms, Experimental; Sarcoma 180 | 1983 |
[Comparison of the antitumor, immunodepressive and toxic properties of carminomycin-albumin complexes differing in carminomycin content].
Topics: Animals; Antibiotics, Antineoplastic; Antibody Formation; Carubicin; Daunorubicin; Drug Combinations; Drug Evaluation, Preclinical; In Vitro Techniques; Lethal Dose 50; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mice; Neoplasms, Experimental; Serum Albumin, Bovine; Time Factors | 1981 |
[Hematopoietic resistance to the damaging action of cytostatics in the occurrence of tumor drug resistance].
Topics: Animals; Daunorubicin; Drug Evaluation, Preclinical; Drug Resistance; Drug Therapy, Combination; Flavonoids; Fluorouracil; Hematopoiesis; Lymphoma, Non-Hodgkin; Male; Melphalan; Neoplasm Transplantation; Neoplasms, Experimental; Rats | 1981 |
[Synthesis, toxicity and antitumor action of carminomycin azine (carminazine)].
Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Daunorubicin; Drug Evaluation, Preclinical; Hematopoiesis; Lethal Dose 50; Lymphoma, Non-Hodgkin; Male; Mice; Neoplasm Transplantation; Neoplasms, Experimental | 1981 |
[Synthesis of rubomycin 13-tert-butoxycarbonylhydrazone and the study of its antitumor action].
Topics: Animals; Daunorubicin; Drug Evaluation, Preclinical; Lethal Dose 50; Leukemia, Experimental; Lymphoma, Non-Hodgkin; Male; Melanoma; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Time Factors | 1981 |
[Synthesis and study of the antitumor properties of 13-hydrazone-substituted carminomycin].
Topics: Animals; Carubicin; Daunorubicin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Injections, Intravenous; Lethal Dose 50; Lymphoma, Non-Hodgkin; Male; Mice; Neoplasm Transplantation; Neoplasms, Experimental | 1982 |
[Antitumor activity and the effect on immunogenesis of combinations of rubomycin and carminomycin with levamisole].
Topics: Animals; Antibody Formation; Carubicin; Daunorubicin; Dose-Response Relationship, Immunologic; Drug Combinations; Drug Evaluation, Preclinical; Drug Hypersensitivity; Hypersensitivity, Delayed; Immunity, Cellular; Levamisole; Lymphoma, Non-Hodgkin; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental | 1982 |
A seven year laboratory and clinical experience with lithium carbonate as an adjuvant to cancer chemotherapy.
Topics: Bone Marrow Cells; Cells, Cultured; Cytarabine; Daunorubicin; Drug Therapy, Combination; Granulocytes; Humans; Leukemia, Myeloid, Acute; Leukocytosis; Lithium; Lymphoma, Non-Hodgkin; Methotrexate | 1980 |
Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells.
Topics: Apoptosis; Caffeine; Carboplatin; Cluster Analysis; Coloring Agents; Daunorubicin; Drug Resistance, Neoplasm; Flow Cytometry; G2 Phase; Gamma Rays; Gene Expression Regulation, Leukemic; Glutathione; GTP-Binding Proteins; HL-60 Cells; Humans; Immunohistochemistry; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Lymphoma, Non-Hodgkin; Multivariate Analysis; Oncogene Proteins v-fos; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; ras Proteins; S Phase; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1995 |
Evaluation of multidrug resistant phenotype by flow cytometry with monoclonal antibodies and functional tests.
Topics: Antibodies, Monoclonal; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Daunorubicin; Drug Resistance, Multiple; Flow Cytometry; Fluorescent Antibody Technique; Fluorescent Dyes; Humans; Leukemia, Erythroblastic, Acute; Lymphoma, Non-Hodgkin; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rhodamine 123; Rhodamines | 1995 |
Granulocyte colony-stimulating factor (CSF), macrophage-CSF, granulocyte-macrophage CSF, interleukin-3, and interleukin-6 levels in sera from children undergoing blood stem cell autografts.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Cytarabine; Daunorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-3; Interleukin-6; Leukemia, Myeloid, Acute; Leukocyte Count; Lymphoma, Non-Hodgkin; Macrophage Colony-Stimulating Factor; Male; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Transplantation; Time Factors; Transplantation, Autologous | 1993 |
Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Recurrence; Remission Induction; Survival Rate; Teniposide; Thioguanine; Vincristine | 1994 |
Fluorescence imaging studies for the disposition of daunorubicin liposomes (DaunoXome) within tumor tissue.
Topics: Animals; Cell Survival; Daunorubicin; Delayed-Action Preparations; Drug Carriers; Female; Liposomes; Lymphoma, Non-Hodgkin; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Tumor Cells, Cultured | 1996 |
Exacerbation of hepatitis in hepatitis B carriers following chemotherapy for haematological malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carrier State; Chronic Disease; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Progression; Doxorubicin; Etoposide; Female; Hepatic Encephalopathy; Hepatitis B; Humans; Leucovorin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1996 |
Non-transferrin-bound iron induced by myeloablative chemotherapy.
Topics: Adolescent; Adult; Blood Transfusion; Daunorubicin; Female; Hematopoiesis; Hodgkin Disease; Humans; Iron; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Transferrin; Transferrin; Transplantation Conditioning | 1997 |
Oral idarubicin pharmacokinetics--correlation of trough level with idarubicin area under curve.
Topics: Administration, Oral; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Chromatography, High Pressure Liquid; Daunorubicin; Half-Life; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Metabolic Clearance Rate; Middle Aged; Regression Analysis | 1997 |
Primary epidural non-Hodgkin lymphoma: spinal cord compression syndrome as the initial form of presentation in childhood non-Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Daunorubicin; Diagnosis, Differential; Epidural Neoplasms; Fatal Outcome; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Spinal Cord Compression; Syndrome; Treatment Outcome; Vincristine | 1999 |
Idarubicinol myelotoxicity: a comparison of in vitro data with clinical outcome in patients treated with high-dose idarubicin.
Topics: Adult; Antineoplastic Agents; Daunorubicin; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Treatment Outcome | 2000 |
[The analysis of failures in the treatment of children with non-B non-Hodgkin's lymphoma. Polish pediatric leukemia/lymphoma study group report].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasm Staging; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Survival Rate; Treatment Failure; Vincristine | 1998 |
Guillain-Barré syndrome in a patient with non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy, Needle; Daunorubicin; Electromyography; Female; Follow-Up Studies; Guillain-Barre Syndrome; Humans; Immunoglobulins, Intravenous; Lymphoma, Non-Hodgkin; Prednisolone; Treatment Outcome; Vincristine | 2000 |
What can we expect from liposomal drugs?
Topics: Antibiotics, Antineoplastic; Daunorubicin; Drug Delivery Systems; Humans; Liposomes; Lymphoma, Non-Hodgkin | 2001 |
Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Arthroplasty, Replacement, Hip; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Femur Head Necrosis; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Mercaptopurine; Methotrexate; Mitoxantrone; Osteonecrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Factors; Treatment Outcome; Vincristine | 2001 |
Assessment of drug activity and proliferation ex vivo for prediction of outcome in aggressive non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Bleomycin; Cell Division; Cyclophosphamide; Daunorubicin; Doxorubicin; Drug Evaluation; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Immunophenotyping; Ki-67 Antigen; Lymphoma, Non-Hodgkin; Methotrexate; Mitotic Index; Neoplasm Staging; Prednisone; Survival Rate; Teniposide; Treatment Outcome; Vincristine | 2002 |
Non-Hodgkin's malignant lymphomata in adults: chemo-radiotherapy in stages III and IV.
Topics: Adult; Antineoplastic Agents; Azirines; Bleomycin; Cyclophosphamide; Daunorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Prednisone; Procarbazine; Teniposide; Triethylenemelamine; Vinblastine; Vincristine | 1975 |
Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
Topics: Aclarubicin; Animals; Anthraquinones; Antibiotics, Antineoplastic; Cricetinae; Daunorubicin; Doxorubicin; Electrocardiography; Glycosides; Heart; Leukemia L1210; Leukemia, Experimental; Lymphoma, Non-Hodgkin; Male; Mesocricetus; Mice; Mice, Inbred Strains; Sarcoma 180; Sarcoma, Experimental; Streptomyces | 1977 |
Mechanism of adriamycin resistance in a subline of mouse lymphoblastoma L5178Y cells.
Topics: Animals; Cell Line; Cell Nucleus; Daunorubicin; DNA-Directed DNA Polymerase; DNA-Directed RNA Polymerases; Doxorubicin; Drug Resistance; Lymphoma, Non-Hodgkin; Mice; Neoplasms, Experimental; Nucleic Acids; Tritium | 1979 |
[Toxicity and antitumor activity of the antibiotic rubomycin and dipin in combination with diuretics (diacarb)].
Topics: Acetazolamide; Animals; Antibiotics, Antineoplastic; Aziridines; Cyclic P-Oxides; Daunorubicin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Lethal Dose 50; Lymphoma, Non-Hodgkin; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Piperazines | 1976 |
L-asparaginase therapy and its complications in acute lymphoid leukaemia and generalized lymphosarcoma.
Topics: Adolescent; Anaphylaxis; Asparaginase; Child; Child, Preschool; Confusion; Daunorubicin; Female; Hallucinations; Hemorrhage; Humans; Injections, Spinal; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Pancreatitis; Prednisolone; Retroperitoneal Space; Vinblastine; Vincristine | 1976 |
DNA-dependent RNA polymerases of Ehrlich carcinoma, other murine ascites tumors, and murine normal tissues.
Topics: Adenocarcinoma; Amanitins; Animals; Carcinoma, Ehrlich Tumor; Cell Nucleus; Chromatography, Ion Exchange; Daunorubicin; DNA-Directed RNA Polymerases; DNA, Neoplasm; Kidney; Liver; Lymphoma, Non-Hodgkin; Magnesium; Male; Manganese; Mice; Molecular Weight; Neoplasms, Experimental; RNA, Ribosomal; Species Specificity; Spleen; Temperature; Templates, Genetic | 1975 |
[Lymphosarcoma of the stomach in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Child; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Female; Fiber Optic Technology; Gastroscopy; Humans; Lymphoma, Non-Hodgkin; Male; Prednisolone; Radiography; Stomach; Stomach Neoplasms; Time Factors; Vincristine | 1992 |
[Disparity of the bone marrow involvement in a 5-year-old boy with primary non-Hodgkin's malignant lymphoma of the bone].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Neoplasms; Child, Preschool; Daunorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Radius; Vincristine | 1992 |
Differences in the intracellular pharmacokinetics of cytosine arabinoside (AraC) between circulating leukemic blasts and normal mononuclear blood cells.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Cytarabine; Daunorubicin; Drug Administration Schedule; Humans; Leukemia, Myeloid; Leukocytes, Mononuclear; Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thioguanine | 1992 |
Growth after radiotherapy and chemotherapy in children with leukemia or lymphoma.
Topics: Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Height; Body Weight; Child; Child, Preschool; Daunorubicin; Dose-Response Relationship, Radiation; Female; Growth; Humans; Lymphoma, Non-Hodgkin; Male; Multivariate Analysis; Pituitary Gland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Somatomedins; Vincristine | 1992 |
[Results of modified LSA2-L2 protocol with moderate-dose MTX therapy in children with untreated non-Hodgkin's lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Nimustine; Prednisone; Remission Induction; Vincristine | 1992 |
Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors.
Topics: Adenocarcinoma; Animals; Biological Availability; Daunorubicin; Drug Carriers; Liposomes; Lymphoma, Non-Hodgkin; Mammary Neoplasms, Animal; Mice; Tissue Distribution | 1992 |
[Kinetics of circulating hematopoietic stem cells following chemotherapy in patients with hematopoietic malignancies].
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Colony-Stimulating Factors; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Middle Aged; Multiple Myeloma; Prednisolone; Prednisone; Vincristine | 1990 |
[Study of toxicity and antineoplastic activity of 14-substituted derivatives of rubomycin and carminomycin].
Topics: Animals; Carubicin; Daunorubicin; Drug Evaluation, Preclinical; Female; Leukemia P388; Leukemia, Experimental; Lymphoma, Non-Hodgkin; Male; Mice; Neoplasms, Experimental | 1990 |
UKALL X--an effective treatment for stage III mediastinal non-Hodgkin's lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Vincristine | 1990 |
[Production and antineoplastic activity of new asymmetric azines on the rubomycin base].
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Daunorubicin; Drug Combinations; Drug Compounding; Drug Screening Assays, Antitumor; Hydrazones; Lymphoma, Non-Hodgkin; Mice; USSR | 1990 |
[Pharmacokinetics of 57Co-bleomycetin A5 in mice with LYO-1 lymphosarcoma during treatment with rubomycin].
Topics: Animals; Bleomycin; Cobalt Radioisotopes; Daunorubicin; Kinetics; Lymphoma, Non-Hodgkin; Mice; Radionuclide Imaging | 1986 |
Childhood non-Hodgkin's lymphoma and "leukemia-lymphoma syndrome": long-term results with the modified LSA2-L2 protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Daunorubicin; Diagnosis, Differential; Evaluation Studies as Topic; Humans; Italy; Life Tables; Lymphoma, Non-Hodgkin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Survival Rate; Syndrome; Vincristine | 1986 |
[Non-Hodgkin's lymphomas in childhood. Evaluation of therapeutic results according to histopathologic criteria (Catalan Interhospital Group of Pediatric Oncology)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Vincristine | 1988 |
Non-Hodgkin's lymphoma in children; diffuse lymphoblastic histology; diffuse non-lymphoblastic histology; LSA2-L2 experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Vincristine | 1988 |
[Non-Hodgkin's lymphoma. Results of a therapeutic protocol].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Staging; Prednisone; Vincristine | 1988 |
[Results of the treatment of 46 non-Hodgkin's lymphomas in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine | 1988 |
[Evaluation of the results of treatment of non-Hodgkin's lymphoma in children by the Wollner method].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Daunorubicin; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Time Factors; Vincristine | 1988 |
Factors of prognostic importance in childhood non-Hodgkin's lymphoma treated with two modified LSA2-L2 protocols. A multivariate analysis approach.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carmustine; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Nutritional Status; Prednisone; Prognosis; Time Factors; Vincristine | 1988 |
[Results of treatment in children with diffuse large cell lymphoma].
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine | 1987 |
Oral idarubicin in non-Hodgkin's lymphomas.
Topics: Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Blood; Daunorubicin; Female; Heart; Humans; Idarubicin; Lymphoma, Non-Hodgkin; Male; Middle Aged | 1986 |
Intermediate and high-dose cytosine arabinoside-containing regimens for induction and consolidation therapy for patients with acute lymphoblastic leukemia and lymphoblastic non-Hodgkin's lymphoma: the Leyden experience and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1987 |
[non-Hodgkin's lymphoma treated with modified LSA2-L2 protocol--a clinical experience and case report].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Remission Induction; Vincristine | 1987 |
[Synthesis and antitumor action of 14-N-substituted derivatives of rubomycin and karminomycin].
Topics: Animals; Bacillus; Carubicin; Daunorubicin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Lethal Dose 50; Lymphoma, Non-Hodgkin; Male; Mice; Neoplasm Transplantation; Structure-Activity Relationship | 1987 |
[Clinical picture and treatment of lesions of the epidural space in lymphosarcoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Epidural Space; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pain; Prednisolone; Spinal Neoplasms; Vincristine | 1986 |
[Non-Hodgkinś lymphoma in childhood, preliminary results of the LSA2 L2 protocol modified by high-dose methotrexate].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine | 1987 |
Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aminoacridines; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Fever; Humans; Intercalating Agents; Intestinal Obstruction; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Middle Aged; Nausea; Time Factors; Vomiting | 1985 |
Daunomycin in the treatment of acute leukaemia and neoplastic diseases in childhood.
Topics: Adenocarcinoma; Age Factors; Child; Child, Preschool; Daunorubicin; Female; Hemangiosarcoma; Hodgkin Disease; Humans; Infant; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Neoplasm Recurrence, Local; Neoplasms; Neuroblastoma; Peritoneal Neoplasms; Sarcoma, Ewing; Teratoma; Testicular Neoplasms; Wilms Tumor | 1968 |
[Acute heart failure after a moderate dose of rubidomycin].
Topics: Acute Disease; Antibiotics, Antineoplastic; Arrhythmias, Cardiac; Daunorubicin; Electrocardiography; Head and Neck Neoplasms; Heart Failure; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged | 1972 |
[The treatment of lymphosarcoma in childhood (author's transl)].
Topics: Age Factors; Antineoplastic Agents; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Evaluation Studies as Topic; Humans; Injections, Intravenous; Injections, Spinal; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Prednisone; Prognosis; Vincristine | 1974 |
Adriamycin in the treatment of acute leukaemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Child; Child, Preschool; Cytarabine; Daunorubicin; Drug Resistance; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Remission, Spontaneous | 1972 |
Lymphosarcoma terminating in acute myelogenous leukemia.
Topics: Adult; Cobalt Isotopes; Cyclophosphamide; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Radioisotope Teletherapy; Radiotherapy Dosage; Uracil Mustard | 1972 |
[The effect of cytostatic therapy on hemodynamics (author's transl)].
Topics: Adult; Aged; Antineoplastic Agents; Blood Circulation Time; Blood Pressure; Cardiac Output; Cardiac Volume; Child; Child, Preschool; Cortisone; Cytarabine; Daunorubicin; Digoxin; Electrocardiography; Female; Heart Failure; Heart Function Tests; Hemodynamics; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Sex Factors; Time Factors; Vincristine | 1974 |
Morphologic studies in a recently described dyserythropoietic state.
Topics: Bone Marrow Cells; Cell Nucleus; Cell Survival; Child; Chromatids; Chromium Isotopes; Chromosome Aberrations; Chromosomes, Human, 1-3; Cyclophosphamide; Cytoplasm; Daunorubicin; Electrophoresis, Starch Gel; Erythrocytes, Abnormal; Erythropoiesis; Fetal Hemoglobin; Hematopoietic Stem Cells; Hemolysis; Humans; Iron; Karyotyping; Lymphoma, Non-Hodgkin; Male; Megakaryocytes; Microscopy, Electron; Osmotic Fragility; Phagocytosis; Vincristine | 1972 |
[Daunomycin therapy of lymphogranuloma and reticulosarcoma].
Topics: Daunorubicin; Hodgkin Disease; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Thrombocytopenia | 1967 |
[A new scheme of chemotherapy and radiotherapy in the treatment of reticulosarcoma. Evaluation of the early results].
Topics: Antimetabolites; Benzoates; Cyclophosphamide; Daunorubicin; Humans; Lymphoma, Non-Hodgkin; Vincristine | 1968 |
Urinary polyamines in cancer patients.
Topics: Brain Neoplasms; Chemistry, Clinical; Daunorubicin; Female; Hodgkin Disease; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms; Ovarian Neoplasms; Polyamines; Pregnancy; Remission, Spontaneous; Spermidine; Spermine; Teratoma | 1971 |
[Daunoblastine in the treatment of leukemias and lymphoreticular neoplasms].
Topics: Daunorubicin; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Waldenstrom Macroglobulinemia | 1969 |
Combination chemotherapy with L-asparaginase (EC-2) using P1798 lymphosarcoma.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Azaserine; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Fluorouracil; Hydrocarbons, Halogenated; Lymphoma, Non-Hodgkin; Mercaptopurine; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Prednisolone; Remission, Spontaneous; Sarcoma, Experimental; Thiotepa; Time Factors; Triethylenemelamine; Vinblastine; Vincristine | 1971 |
[Results obtained with the clinical use of adriamycin].
Topics: Adult; Aged; Amino Sugars; Antibiotics, Antineoplastic; Daunorubicin; Female; Glycosides; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Naphthacenes; Neoplasms; Plasmacytoma; Remission, Spontaneous | 1971 |
Daunorubicin therapy in adult acute lymphatic leukemia.
Topics: Adolescent; Adult; Bone Marrow; Daunorubicin; Female; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Time Factors | 1972 |
Daunomycin inhibition of DNA and RNA synthesis.
Topics: Animals; Ascitic Fluid; Daunorubicin; DNA, Neoplasm; Female; In Vitro Techniques; Injections, Intraperitoneal; Liver Regeneration; Lymphoma, Non-Hodgkin; Male; Mice; Neoplasms, Experimental; Phospholipids; Phosphorus Isotopes; RNA, Neoplasm | 1968 |